SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-156020
Filing Date
2018-05-08
Accepted
2018-05-08 16:23:11
Documents
4
Effectiveness Date
2018-05-08

Document Format Files

Seq Description Document Type Size
1 S-8 d573820ds8.htm S-8 50776
2 EX-5.1 d573820dex51.htm EX-5.1 6707
3 EX-23.1 d573820dex231.htm EX-23.1 1636
4 GRAPHIC g573820snap0004.jpg GRAPHIC 3209
  Complete submission text file 0001193125-18-156020.txt   64696
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-224748 | Film No.: 18814950
SIC: 2834 Pharmaceutical Preparations